New Republic Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Buy
+535
New +$198K 0.05% 271
2026
Q1
Sell
-1,280
Closed -$449K 337
2025
Q4
$449K Buy
+1,280
New +$433K 0.12% 158
2024
Q3
Sell
-406
Closed -$220K 244
2024
Q2
$220K Buy
+406
New +$215K 0.11% 160

Other funds holding ELV

New Republic Capital's ELV Position: Q2 2026 in Review

New Republic Capital opened a new position in Elevance Health (ELV) in Q2 2026: 535 shares worth $207K. The stake represents 0.05% of the portfolio and ranks #271 among its holdings. This is a return to the name: New Republic Capital previously reported a position in ELV as recently as Q4 2025.

New Republic Capital first reported a position in ELV in Q2 2024 and has held it in 3 quarters since. The position peaked at $449K in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • New Republic Capital held 535 shares of Elevance Health worth $207K as of Q2 2026.
  • Elevance Health was a new New Republic Capital position in Q2 2026.
  • Elevance Health made up 0.05% of New Republic Capital's portfolio in Q2 2026, its #271 holding.
  • New Republic Capital first reported a position in Elevance Health in Q2 2024 and has held it in 3 quarters since.
  • New Republic Capital's Elevance Health position peaked at $449K in Q4 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.